神思電子(300479.SZ)取得2項發明專利證書
格隆匯5月6日丨神思電子(300479.SZ)公佈,公司近日收到中華人民共和國國家知識產權局授予的兩項發明專利證書,專利名稱為:一種自助設備的輔助交互方法與裝置;一種用於多輪對話中相同槽值填充的方法。
以上兩項發明專利主要應用於“智慧營業廳”相關的AI雲服務解決方案,其中“一種自助設備的輔助交互方法與裝置”通過人體感應模塊檢測用户,對用户語音進行分析處理,為用户提供智能諮詢、指導服務,完成自助設備主屏的人工智能升級,降低人工成本;“一種用於多輪對話中相同槽值填充的方法”能夠很好地解決具有相同槽值下的多輪問答槽值衝突問題,增強多輪對話的靈活性,提升用户的體驗感。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.